ABSTRACT
Background/aims Healthcare workers (HCWs) are at an increased risk of infection and mortality associated with the COVID-19 pandemic. This study determined the illness severity and mortality amongst COVID-19 infected healthcare workers.
Methods The current study was a retrospective cohort study using population-level data. Secondary analysis was conducted on collated data from the Public Health Emergency Operations Centre (PHEOC) at the State Ministry of Health. The cohort included all documented healthcare workers with confirmed COVID-19 infection (diagnosed by Polymerase Chain Reaction). Data were gathered from the COVID-19 patient database of the PHEOC, on demographics, place of work, illness severity and outcome. Descriptive statistics were reported on the cohort characteristics. Adjusted odds ratio was used to report the measure of association between illness severity and risk factors.
Results The mean age was 43 years and 50.5% of the cohort were female. Of the 301 healthcare workers, 187 patients were symptomatic with 32 requiring hospitalisation. From the available data, seven infected HCWs died of their COVID-19 infection, resulting in a case fatality ratio of 2.3%. A subgroup analysis was conducted on the health professionals infected –doctors (71.7%), nurses (27.3%), others (1%). Symptomatic cases were more inclined to progress to severe illness. Predictors of mortality assessed included age, sex, case class and illness severity. The logistic regression model was statistically significant, χ2(9) = 16.965, α = 0.049.
Conclusion Frontline healthcare workers are at an increased risk of exposure to COVID-19 infections. In Nigeria, there is a higher risk of experiencing a severe disease if symptomatic while infected with COVID-19. It is imperative that preventive strategies, proper education, and awareness are put in place to protect healthcare workers.
Summary Box Healthcare workers as first responders, are vulnerable to workplace infections. It is manifest in the COVID-19 pandemic where deaths of healthcare workers resulted in further shortage of the already compromised human resource; consequently compromising effective healthcare delivery. As the pandemic progresses, studies have been conducted globally on this topic and scientific evidence continues to show higher mortality and disease severity of COVID-19. Nevertheless, it is important to understand the effect of COVID-19 on healthcare workers in Nigeria-a developing country.
This study highlights the illness severity and mortality associated with COVID-19 among the study population; its results presented a higher case fatality rate than both national and subnational rates. The results also further emphasises the need to protect healthcare workers; ensure they are knowledgable in both infection prevention and control, and that the healthcare space is safe against nosocomial infections
The study adds to the scientific evidence on the severity and mortality associated with COVID-19 in Nigeria. A national research is needed to extrapolate the findings from this study to the nation. Hence, expatiate on the global fight against coronaviruses such as COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of the Rivers State Ministry of Health gave ethical approval for this work with Ethics ID: MH/PRS/391/VOL.2/809
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the Rivers State Ministry of Health